{"id":"https://openalex.org/W2155254553","doi":"https://doi.org/10.1176/foc.8.4.foc592","title":"Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs","display_name":"Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs","alternate_titles":[],"publication_year":2010,"publication_date":"2010-10-01","ids":{"openalex":"https://openalex.org/W2155254553","doi":"https://doi.org/10.1176/foc.8.4.foc592","mag":"2155254553"},"language":"en","primary_location":{"id":"doi:10.1176/foc.8.4.foc592","doi":"https://doi.org/10.1176/foc.8.4.foc592","is_oa":false,"landing_page_url":"https://doi.org/10.1176/foc.8.4.foc592","pdf_url":null,"source":{"id":"https://openalex.org/S4210193920","display_name":"FOCUS The Journal of Lifelong Learning in Psychiatry","issn_l":"1541-4094","issn":["1541-4094","1541-4108"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","norway-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Focus","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2155254553"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050356892","display_name":"Charles B. Nemeroff","orcid":"https://orcid.org/0000-0001-7867-1160","observed_orcids":["https://orcid.org/0000-0001-7867-1160"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charles B. Nemeroff","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004986917","display_name":"Richard Entsuah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Entsuah","raw_affiliation_strings":["Wyeth Research, Collegeville, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012750874","display_name":"Isma Benattia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Isma Benattia","raw_affiliation_strings":["Wyeth Research, Collegeville, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078128383","display_name":"Mark A. Demitrack","orcid":"https://orcid.org/0000-0001-7029-0646","observed_orcids":["https://orcid.org/0000-0001-7029-0646"]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Demitrack","raw_affiliation_strings":["Wyeth Research, Collegeville, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Diane M. Sloan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Diane M. Sloan","raw_affiliation_strings":["Advogent, Wayne, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advogent, Wayne, New Jersey","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085107940","display_name":"Michael E. Thase","orcid":"https://orcid.org/0000-0002-6403-0861","observed_orcids":["https://orcid.org/0000-0002-6403-0861","https://orcid.org/0009-0002-3646-845X"]},"institutions":[{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael E. Thase","raw_affiliation_strings":["Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I4210134769"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":9.9293,"has_fulltext":false,"cited_by_count":126,"citation_normalized_percentile":{"value":0.98850218,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"8","issue":"4","first_page":"592","last_page":"604"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8339999914169312},{"id":"https://openalex.org/keywords/depression-remission","display_name":"depression remission","score":0.8939999938011169},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9229999780654907},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.9340000152587891},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":0.9959999918937683},{"id":"https://openalex.org/keywords/citalopram","display_name":"citalopram","score":0.9909999966621399},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.8220000267028809},{"id":"https://openalex.org/keywords/number-needed-to-treat","display_name":"number needed to treat","score":0.7409999966621399},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7250000238418579},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.6809999942779541},{"id":"https://openalex.org/keywords/pharmaceutical-industry-influence","display_name":"pharmaceutical industry influence","score":0.3880000114440918},{"id":"https://openalex.org/keywords/hamilton-depression-rating-scale","display_name":"Hamilton Depression Rating Scale","score":0.6159999966621399},{"id":"https://openalex.org/keywords/rem-sleep","display_name":"REM sleep","score":0.35899999737739563}],"concepts":[{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.941218912601471},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.83026522397995},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.8026677966117859},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.7790957689285278},{"id":"https://openalex.org/C2777490545","wikidata":"https://www.wikidata.org/wiki/Q409672","display_name":"Citalopram","level":4,"score":0.6829732060432434},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6676974296569824},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.583558201789856},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.5491795539855957},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5151752233505249},{"id":"https://openalex.org/C2909532165","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine Hydrochloride","level":5,"score":0.4732903838157654},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.46821215748786926},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.4672199487686157},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4546622633934021},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4372175335884094},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42643028497695923},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4193773865699768},{"id":"https://openalex.org/C67774102","wikidata":"https://www.wikidata.org/wiki/Q614132","display_name":"Number needed to treat","level":4,"score":0.41517460346221924},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.38063329458236694},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3750208914279938},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.297161340713501},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.19592663645744324},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.11244133114814758},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1176/foc.8.4.foc592","doi":"https://doi.org/10.1176/foc.8.4.foc592","is_oa":false,"landing_page_url":"https://doi.org/10.1176/foc.8.4.foc592","pdf_url":null,"source":{"id":"https://openalex.org/S4210193920","display_name":"FOCUS The Journal of Lifelong Learning in Psychiatry","issn_l":"1541-4094","issn":["1541-4094","1541-4108"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","norway-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Focus","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W80099719","https://openalex.org/W1506129694","https://openalex.org/W1964435302","https://openalex.org/W1965492856","https://openalex.org/W1966276773","https://openalex.org/W1975870015","https://openalex.org/W1988861786","https://openalex.org/W1989007151","https://openalex.org/W1994024655","https://openalex.org/W1996105921","https://openalex.org/W1999329221","https://openalex.org/W2001618362","https://openalex.org/W2001949258","https://openalex.org/W2007043965","https://openalex.org/W2014493656","https://openalex.org/W2017810918","https://openalex.org/W2018008180","https://openalex.org/W2026943977","https://openalex.org/W2027993289","https://openalex.org/W2031358990","https://openalex.org/W2031918577","https://openalex.org/W2033585778","https://openalex.org/W2036861336","https://openalex.org/W2039979496","https://openalex.org/W2045531480","https://openalex.org/W2045775503","https://openalex.org/W2046793183","https://openalex.org/W2047749428","https://openalex.org/W2048340122","https://openalex.org/W2056513437","https://openalex.org/W2059171296","https://openalex.org/W2060878519","https://openalex.org/W2065570210","https://openalex.org/W2068083208","https://openalex.org/W2068124573","https://openalex.org/W2068790373","https://openalex.org/W2076065290","https://openalex.org/W2083991574","https://openalex.org/W2088302707","https://openalex.org/W2099564543","https://openalex.org/W2101963851","https://openalex.org/W2104058480","https://openalex.org/W2110183017","https://openalex.org/W2111149452","https://openalex.org/W2119660434","https://openalex.org/W2126930838","https://openalex.org/W2129604620","https://openalex.org/W2148580139","https://openalex.org/W2149449160","https://openalex.org/W2155891669","https://openalex.org/W2157823046","https://openalex.org/W2158131361","https://openalex.org/W2160070901","https://openalex.org/W2162966898","https://openalex.org/W2164706851","https://openalex.org/W2167761850","https://openalex.org/W2170691050","https://openalex.org/W2172129050","https://openalex.org/W2977382310","https://openalex.org/W4244103373","https://openalex.org/W4249121523"],"related_works":["https://openalex.org/W2051753790","https://openalex.org/W2099564543","https://openalex.org/W1981792453","https://openalex.org/W1985993871","https://openalex.org/W1972652362","https://openalex.org/W2352770270","https://openalex.org/W1977126872","https://openalex.org/W2071410273","https://openalex.org/W1985514300","https://openalex.org/W4249281884"],"abstract_inverted_index":{"Background:":[0],"To":[1],"compare":[2],"venlafaxine":[3,49,102,212,229],"and":[4,14,22,143,190,218,281],"selective":[5],"serotonin":[6],"reuptake":[7],"inhibitors":[8],"(SSRIs;":[9],"fluoxetine,":[10],"sertraline,":[11],"paroxetine,":[12],"fluvoxamine,":[13],"citalopram)":[15],"in":[16,95],"the":[17,115,129,134,141,149,152,254,273,282],"treatment":[18],"of":[19,25,35,247,257,264,268,276,285],"depression.":[20],"Methods":[21],"Materials:":[23],"Meta-analysis":[24],"34":[26],"randomized,":[27],"double-blind":[28],"studies":[29,63],"identified":[30],"by":[31,39],"a":[32,66,237],"worldwide":[33],"search":[34],"all":[36],"research":[37],"sponsored":[38],"Wyeth":[40],"Pharmaceuticals":[41],"through":[42],"January":[43],"2007.":[44],"Patients":[45],"were":[46,137,200,209],"treated":[47,278],"with":[48,211,214,288,292],"(n":[50,59,70],"=":[51,60,71,158,175,184,194,222],"4191;":[52],"mean":[53],"dose":[54,157,174,183,193],"151":[55],"mg/day)":[56],"or":[57],"SSRIs":[58,142,235],"3621);":[61],"nine":[62,130],"also":[64],"included":[65],"placebo":[67,131],"control":[68],"group":[69],"932).":[72],"The":[73,92,244],"primary":[74],"outcome":[75],"measure":[76],"was":[77,99,163],"intent-to-treat":[78],"(ITT)":[79],"remission":[80,97],"rates":[81,98,204],"(Hamilton":[82],"Rating":[83],"Scale":[84],"for":[85,140,146,253,279],"Depression":[86],"\u22647)":[87],"at":[88],"week":[89],"8.":[90],"Results:":[91],"overall":[93],"difference":[94,153],"ITT":[96],"5.9%":[100],"favoring":[101],"(95%":[103,125],"confidence":[104],"interval":[105],"[CI]:":[106],".038\u2013.081;":[107],"p":[108],"<":[109],".001).":[110],"Based":[111],"on":[112],"this":[113,248,289],"difference,":[114],"number":[116,275],"needed":[117],"to":[118,121,206,234,241],"treat":[119],"(NNT)":[120],"benefit":[122],"is":[123,231],"17":[124,265],"CI:":[126,167],"12\u201326).":[127],"In":[128],"controlled":[132],"studies,":[133],"drug-placebo":[135],"differences":[136,170],"6%":[138],"(.02\u2013.09)":[139],"13%":[144],"(.09\u2013.16)":[145],"venlafaxine.":[147],"For":[148],"specific":[150],"SSRIs,":[151],"versus":[154,171],"fluoxetine":[155,242],"(mean":[156,173,182,192],"37":[159],"mg/day;":[160,177,186,196],"20":[161],"studies)":[162],"significant":[164,283],"(6.6%":[165],"[95%":[166],".030\u2013.095]);":[168],"smaller":[169],"paroxetine":[172],"25":[176],"eight":[178],"studies;":[179,188,198],"5%),":[180],"sertraline":[181],"127":[185],"three":[187],"3%),":[189],"citalopram":[191],"38":[195],"two":[197],"4%)":[199],"not":[201],"significant.":[202],"Attrition":[203],"due":[205],"adverse":[207],"events":[208],"higher":[210],"than":[213],"SSRI":[215],"therapy,":[216],"11%":[217],"9%":[219],"respectively":[220],"(p":[221],".0011).":[223],"Conclusions:":[224],"These":[225],"results":[226],"indicate":[227],"that":[228],"therapy":[230],"statistically":[232],"superior":[233],"as":[236],"class,":[238],"but":[239],"only":[240],"individually.":[243],"clinical":[245],"significance":[246],"modest":[249],"advantage":[250],"seems":[251],"limited":[252],"broad":[255],"grouping":[256],"major":[258],"depressive":[259],"disorder.":[260,290],"Nonetheless,":[261],"an":[262],"NNT":[263],"may":[266],"be":[267],"public":[269],"health":[270],"relevance":[271],"given":[272],"large":[274],"patients":[277],"depression":[280],"burden":[284],"illness":[286],"associated":[287],"(Reprinted":[291],"permission":[293],"from":[294],"Biological":[295],"Psychiatry":[296],"2008;":[297],"63:424\u2013434)":[298]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2155254553","counts_by_year":[{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
